Technology and advances in research proactively push forward to fight against a wide range of complex diseases called cancer. New drugs are being discovered, and innovative therapies are emerging every year, helping millions of cancer patients get back to their everyday healthy lives. However, many people are still pondering the question: will we ever get to the point where all cancers are cured?
Kevin Dalby, UT Austin professor at the Department of Oncology in the College of Pharmacy, is an expert in cancer drug discovery and is studying cancer cell signaling mechanisms to develop targeted therapeutics. In the classroom at UT Austin, Kevin Dalby encourages his students to research to understand cancer better to create new treatments. Below, Dr. Dalby explains why it’s hard to say if all cancers will ever be treated successfully.
"Due to the vast range of complicated and diverse factors that make up these diseases, finding a universal cure is extremely difficult. However, I refrain from saying that such a task is impossible due to my optimistic view about the future of cancer treatments. Emerging advancements in both technology and biotechnology are paving an auspicious way. But needless to say, scientists, physicians, clinicians, and researchers still are up against some very tough challenges as progression takes steps closer to finding a cure,” said Kevin Dalby, UT Austin Department of Oncology professor.
For those unfamiliar, to understand a little more about the challenges scientists on the frontlines face when it comes to finding a cure for cancer, it is essential to grasp the difference between a cure and remission. Time is a factor in determining what “cured” means. If someone is cured of cancer, cancer has been eliminated from the body, and there are no traces left behind.
On the other hand, a patient in remission has little to no signs of cancer in the body. Complete remission means that a patient has no identifiable traces of cancer symptoms left in the body. Even though an individual might be in remission or complete remission, cancer cells can still linger in their body. If cancer cells remain in the body, that means that there is a chance of the disease’s return, which typically occurs within the first five years after treatment.
Some physicians consider an individual cured if cancer has not returned after five years. Unfortunately, one of the hurdles cancer creates for scientists is that it can come back after five years, meaning that it takes time to discover if the treatment was successful.
Emerging treatments paving the way for a cure include immunotherapy, which helps the immune system fight off cancer cells.
Originally published on scienceworldreport.com Many young aspiring scientists question if they need a Ph.D. to conduct research. Even though the conventional belief is that you need to be a doctor to succeed, a few scientists have historically managed to become famous without a doctorate. Here, Kevin Dalby - a professor of chemical biology and medicinal chemistry at The University of Texas in Austin , answers whether you need a Ph.D. to become a researcher and features a few outliers - scientists who never got their Ph.D. but became successful and even famous. One way to think about obtaining a Ph.D. is to envision that your career as a scientist is a 12,000-foot mountain, and you are standing at the base. What you want to achieve, the discoveries you want to make, and the papers you would like to publish are all at, or near, the top of the mountain. There is a chair lift running to a point near the top of the mountain, and a doctorate is your lift ticket. It will take several more
Originally published on einnews.com Kevin Dalby, UT Austin professor comments on how cancer research clinical trials work and why they are so crucial for the future of cancer treatments. AUSTIN, TEXAS, UNITED STATES, April 20, 2021 /EINPresswire.com/ -- Kevin Dalby, UT Austin professor at the College of Pharmacy, knows the ins and outs of how cancer research trials work. He studies the mechanisms of cancer cell signaling to develop targeted therapeutics. Dalby’s efforts were recognized by the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health, granting him nearly $5 million to support his research. Clinical trials are studies with the main focus of research surrounding a specific disease that involves people. These studies use and observe a new treatment approach to diseases such as a type or stage of cancer and compare it to the most effective treatment known at that time. They bring new waves of innovation to the medical world to find